Clopidogrel Bisulphate 75mg + Aspirin 75mg is a dual antiplatelet therapy (DAPT) combination used to prevent the formation of harmful blood clots in patients at risk of cardiovascular events. This combination includes: Clopidogrel – A P2Y12 platelet aggregation inhibitor that prevents platelets from sticking together. Aspirin – An antiplatelet and anti-inflammatory agent that inhibits thromboxane A2 formation, reducing clot formation. This fixed-dose combination is commonly prescribed for patients with: Acute coronary syndrome (ACS) Recent myocardial infarction (heart attack) Ischemic stroke Peripheral arterial disease After angioplasty with stent placement By combining two different mechanisms of platelet inhibition, this therapy significantly reduces the risk of recurrent heart attacks, strokes, and cardiovascular death.
